EISAI INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

First Posted Date
2006-08-24
Last Posted Date
2013-05-20
Lead Sponsor
Eisai Inc.
Target Recruit Count
752
Registration Number
NCT00368108
Locations
🇺🇸

Lehigh Valley Hospital, Allentown, Pennsylvania, United States

🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

and more 111 locations

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-08-24
Last Posted Date
2015-12-10
Lead Sponsor
Eisai Inc.
Target Recruit Count
138
Registration Number
NCT00368472

A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2006-08-04
Last Posted Date
2014-07-11
Lead Sponsor
Eisai Inc.
Target Recruit Count
997
Registration Number
NCT00360412
Locations
🇩🇪

Philipps-University Marburg, Marburg, Germany

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-08-01
Last Posted Date
2013-05-20
Lead Sponsor
Eisai Inc.
Target Recruit Count
55
Registration Number
NCT00358644

E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

First Posted Date
2006-06-15
Last Posted Date
2020-06-18
Lead Sponsor
Eisai Inc.
Target Recruit Count
1276
Registration Number
NCT00337103
Locations
🇧🇪

Institut Jules Bordet, Medical Oncology Unit, Brussels, Belgium

🇦🇺

Royal Perth Hospital, Perth, Western Australia, Australia

🇦🇺

Bankstown Hospital, Oncology Trials Unit, Bankstown, New South Wales, Australia

and more 65 locations

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-06-08
Last Posted Date
2017-07-25
Lead Sponsor
Eisai Inc.
Target Recruit Count
2000
Registration Number
NCT00334828

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-06-08
Last Posted Date
2021-06-14
Lead Sponsor
Eisai Inc.
Target Recruit Count
356
Registration Number
NCT00334958
Locations
🇺🇸

University of South Alabama Medical Center, Mobile, Alabama, United States

🇺🇸

Bradenton Research Center, Bradenton, Florida, United States

🇺🇸

Advocate Hope Children's Hospital, Oak Lawn, Illinois, United States

and more 74 locations

A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

Phase 2
Completed
Conditions
First Posted Date
2006-05-18
Last Posted Date
2012-06-20
Lead Sponsor
Eisai Inc.
Target Recruit Count
123
Registration Number
NCT00327392
Locations
🇺🇸

St. Louis Women's Healthcare Group, Chesterfield, Missouri, United States

🇺🇸

International Heart Institute of Montana, Missoula, Montana, United States

🇺🇸

Southern Orthopaedic Sports Medicine, Columbia, South Carolina, United States

and more 12 locations

Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial

Phase 3
Completed
Conditions
First Posted Date
2006-05-18
Last Posted Date
2014-04-21
Lead Sponsor
Eisai Inc.
Target Recruit Count
240
Registration Number
NCT00327730
Locations
🇮🇳

Grant Medical College Sir J.J. Group of Hospitals, Byculla, Mumbai, Maharashtra, India

🇮🇳

L.T. M. Medical College and General Hospital, Sion, Mumbai, Maharashtra, India

🇮🇳

M.R. Medical College, Gulbarga, Karnataka, India

and more 1 locations

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-05-18
Last Posted Date
2014-08-15
Lead Sponsor
Eisai Inc.
Target Recruit Count
240
Registration Number
NCT00327717
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

🇨🇳

Peking Union Hospital, Beijing, Beijing, China

🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

and more 5 locations
© Copyright 2024. All Rights Reserved by MedPath